Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate Compassionate Use for Wet AMD
NCT00211458Phase 2Completed
- Sponsor
- Manhattan Eye, Ear and Throat Hospital
- Start
- Sep 2005
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anecortave in age-related macular degeneration (AMD), sponsored by Manhattan Eye, Ear and Throat Hospital. Started Sep 2005; status: completed.
02
Drugs
anecortave
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00211458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211458.